Publications by authors named "Theodore Oliphant"

Claim this Profile
T
The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor.
Valerie Garceau, Adam Balic, Carla Garcia-Morales, Kristin A Sauter, Mike J McGrew, Theodore Oliphant

BMC Biol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of a novel Fc conjugate of macrophage colony-stimulating factor.
Deborah J Gow, Kristin A Sauter, Clare Pridans, Lindsey Moffat, Anuj Sehgal, Theodore Oliphant

Mol Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro functional characterization of feline IgGs.
Catherine J Strietzel, Lisa M Bergeron, Theodore Oliphant, Veronica T Mutchler, Leszek J Choromanski

Vet Immunol Immunopathol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity.
Timothy S Fisher, Cris Kamperschroer, Theodore Oliphant, Victoria A Love, Paul D Lira

Cancer Immunol Immunother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations within a human IgG2 antibody form distinct and homogeneous disulfide isomers but do not affect Fc gamma receptor or C1q binding.
Sandra Lightle, Serdar Aykent, Nathan Lacher, Vesselin Mitaksov, Kristine Wells, Theodore Oliphant

Protein Sci· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
Matthew R Vogt, Bastiaan Moesker, Jaap Goudsmit, Mandy Jongeneelen, S Kyle Austin, Theodore Oliphant

J Virol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.
Shuliu Zhang, Matthew R Vogt, Theodore Oliphant, Michael Engle, Evgeniy I Bovshik

J Infect Dis· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.
Hameeda Sultana, Harald G Foellmer, Girish Neelakanta, Theodore Oliphant, Michael Engle

J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The host immunologic response to West Nile encephalitis virus.
Michael S Diamond, Erin Mehlhop, Theodore Oliphant, Melanie A Samuel

Front Biosci (Landmark Ed)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
Steevenson Nelson, Christiane A Jost, Qinq Xu, Jessica Ess, Julie E Martin, Theodore Oliphant

PLoS Pathog· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
Soila Sukupolvi-Petty, S Kyle Austin, Whitney E Purtha, Theodore Oliphant, Grant E Nybakken

J Virol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of epitope-specific neutralizing antibodies against West Nile virus.
Theodore Oliphant, Grant E Nybakken, S Kyle Austin, Qing Xu, Jonathan Bramson

J Virol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular basis of antibody-mediated neutralization of West Nile virus.
Theodore Oliphant, Michael S Diamond

Expert Opin Biol Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.
Theodore C Pierson, Qing Xu, Steevenson Nelson, Theodore Oliphant, Grant E Nybakken

Cell Host Microbe· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
Theodore Oliphant, Grant E Nybakken, Michael Engle, Qing Xu, Christopher A Nelson

J Virol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.
David V Jobes, Melissa Daoust, Vivian T Nguyen, Allan Padua, Faruk Sinangil, Theodore Oliphant

AIDS Res Hum Retroviruses· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.
L Hannah Gould, Jianhua Sui, Harald Foellmer, Theodore Oliphant, Tian Wang

J Virol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis of West Nile virus neutralization by a therapeutic antibody.
Grant E Nybakken, Theodore Oliphant, Syd Johnson, Stephen Burke, Michael S Diamond

Nature· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement activation is required for induction of a protective antibody response against West Nile virus infection.
Erin Mehlhop, Kevin Whitby, Theodore Oliphant, Anantha Marri, Michael Engle

J Virol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
Theodore Oliphant, Michael Engle, Grant E Nybakken, Chris Doane, Syd Johnson

Nat Med· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis